© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, BioLineRx Ltd. (BLRX) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 59.43M. Its average trading volume over the past 3 months is 34.08K, indicating liquidity. These fundamental metrics provide insight into BLRX's underlying financial health and market activity.
BioLineRx Ltd. (BLRX) technical indicators as of December 23, 2025: the SMA 20 is -11.15%, SMA 50 at -15.68%, and SMA 200 at -22.29%. The RSI 14 value is 35.33, suggesting its current momentum. These technical analysis signals help assess BLRX's price trends and potential future movements.
BioLineRx Ltd. (BLRX) stock performance overview as of December 23, 2025: The 52-week high is $14.7 (currently -80.4% below), and the 52-week low is $2.3 (currently 25.21% above). Over the past year, BLRX's performance is -66.36%, compared to the S&P 500's 10.56% change.
According to market data, BioLineRx Ltd. (BLRX) stock's recent performance metrics show that over the last month, BLRX is -13.51%, with a Year-to-Date (YTD) performance of -66.36%. Over the past year, the stock has seen a -66.36% change. These figures summarize BLRX's price movements across various periods, reflecting its historical returns.
According to current financial data, BLRX stock's P/E (TTM) ratio is -1.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for BLRX, including P/S (0.74), P/B (0.57), and P/FCF (-0.60), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.